Chemoinformaics analysis of Dihydrowogonin
Molecular Weight | 286.283 | nRot | 2 |
Heavy Atom Molecular Weight | 272.171 | nRig | 18 |
Exact Molecular Weight | 286.084 | nRing | 3 |
Solubility: LogS | -3.754 | nHRing | 1 |
Solubility: LogP | 3.017 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
nHA | 5 | APOL | 40.0651 |
nHD | 2 | BPOL | 18.3849 |
QED | 0.887 |
Synth | 2.866 |
Natural Product Likeliness | 1.755 |
NR-PPAR-gamma | 0.934 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.503 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.869 |
MDCK | 0.0000158 |
BBB | 0.063 |
PPB | 0.963301 |
VDSS | 0.453 |
FU | 0.034281 |
CYP1A2-inh | 0.855 |
CYP1A2-sub | 0.687 |
CYP2c19-inh | 0.806 |
CYP2c19-sub | 0.274 |
CYP2c9-inh | 0.848 |
CYP2c9-sub | 0.899 |
CYP2d6-inh | 0.791 |
CYP2d6-sub | 0.409 |
CYP3a4-inh | 0.671 |
CYP3a4-sub | 0.235 |
CL | 8.402 |
T12 | 0.474 |
hERG | 0.077 |
Ames | 0.128 |
ROA | 0.813 |
SkinSen | 0.9 |
Carcinogencity | 0.402 |
EI | 0.927 |
Respiratory | 0.572 |
NR-Aromatase | 0.056 |
Antiviral | Yes |
Prediction | 0.886942 |